The Adrenal Gland Volume Measurements in Manifestation of the Metabolic Status in Type-2 Diabetes Mellitus Patients
Objectives. The aim of our study was to investigate the differences in adrenal gland volume between nondiabetic controls and Type-2 diabetic patients and to examine the influence of glycemic control in diabetes mellitus on adrenal gland volume. Methods. From March 2 to November 25, 2015, 62 consecut...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2016/7195849 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556952814616576 |
|---|---|
| author | Ismail Serifoglu Ibrahim Ilker Oz Muammer Bilici |
| author_facet | Ismail Serifoglu Ibrahim Ilker Oz Muammer Bilici |
| author_sort | Ismail Serifoglu |
| collection | DOAJ |
| description | Objectives. The aim of our study was to investigate the differences in adrenal gland volume between nondiabetic controls and Type-2 diabetic patients and to examine the influence of glycemic control in diabetes mellitus on adrenal gland volume. Methods. From March 2 to November 25, 2015, 62 consecutive patients with Type-2 DM along with 62 nondiabetics matched by age, gender, and BMI were enrolled in this prospective study. Our diabetes patients were categorized into two groups, well-controlled and poorly controlled diabetes groups. Adrenal volumetric measurements were performed by two radiologists, prospectively and independently, with semiautomatic software. Interobserver reliability was studied using the interobserver correlation coefficient (ICC). Results. The total adrenal volume (TAV) was significantly higher in Type-2 diabetic patients when compared with nondiabetic patients (p<0.05). When we investigated diabetic patients according to glycemic controls, the TAVs in controlled diabetic patients were significantly higher than in those of the poorly controlled or uncontrolled diabetic patients (p<0.05). Nondiabetic control patients have significantly smaller TAVs when compared to controlled and poorly or noncontrolled diabetic patients (p<0.05). Conclusion. Our study suggests that adrenal gland volume measurement may be used as an indirect marker of glycemic control in patients with diabetes. |
| format | Article |
| id | doaj-art-4c4e2ea71ab246ae831dbedc2e698fea |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-4c4e2ea71ab246ae831dbedc2e698fea2025-02-03T05:43:58ZengWileyInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/71958497195849The Adrenal Gland Volume Measurements in Manifestation of the Metabolic Status in Type-2 Diabetes Mellitus PatientsIsmail Serifoglu0Ibrahim Ilker Oz1Muammer Bilici2Department of Radiology, Bagcilar Training and Research Hospital, Istanbul, TurkeyDepartment of Radiology, Bulent Ecevit University School of Medicine, Zonguldak, TurkeyDepartment of Internal Medicine, Bulent Ecevit University School of Medicine, Zonguldak, TurkeyObjectives. The aim of our study was to investigate the differences in adrenal gland volume between nondiabetic controls and Type-2 diabetic patients and to examine the influence of glycemic control in diabetes mellitus on adrenal gland volume. Methods. From March 2 to November 25, 2015, 62 consecutive patients with Type-2 DM along with 62 nondiabetics matched by age, gender, and BMI were enrolled in this prospective study. Our diabetes patients were categorized into two groups, well-controlled and poorly controlled diabetes groups. Adrenal volumetric measurements were performed by two radiologists, prospectively and independently, with semiautomatic software. Interobserver reliability was studied using the interobserver correlation coefficient (ICC). Results. The total adrenal volume (TAV) was significantly higher in Type-2 diabetic patients when compared with nondiabetic patients (p<0.05). When we investigated diabetic patients according to glycemic controls, the TAVs in controlled diabetic patients were significantly higher than in those of the poorly controlled or uncontrolled diabetic patients (p<0.05). Nondiabetic control patients have significantly smaller TAVs when compared to controlled and poorly or noncontrolled diabetic patients (p<0.05). Conclusion. Our study suggests that adrenal gland volume measurement may be used as an indirect marker of glycemic control in patients with diabetes.http://dx.doi.org/10.1155/2016/7195849 |
| spellingShingle | Ismail Serifoglu Ibrahim Ilker Oz Muammer Bilici The Adrenal Gland Volume Measurements in Manifestation of the Metabolic Status in Type-2 Diabetes Mellitus Patients International Journal of Endocrinology |
| title | The Adrenal Gland Volume Measurements in Manifestation of the Metabolic Status in Type-2 Diabetes Mellitus Patients |
| title_full | The Adrenal Gland Volume Measurements in Manifestation of the Metabolic Status in Type-2 Diabetes Mellitus Patients |
| title_fullStr | The Adrenal Gland Volume Measurements in Manifestation of the Metabolic Status in Type-2 Diabetes Mellitus Patients |
| title_full_unstemmed | The Adrenal Gland Volume Measurements in Manifestation of the Metabolic Status in Type-2 Diabetes Mellitus Patients |
| title_short | The Adrenal Gland Volume Measurements in Manifestation of the Metabolic Status in Type-2 Diabetes Mellitus Patients |
| title_sort | adrenal gland volume measurements in manifestation of the metabolic status in type 2 diabetes mellitus patients |
| url | http://dx.doi.org/10.1155/2016/7195849 |
| work_keys_str_mv | AT ismailserifoglu theadrenalglandvolumemeasurementsinmanifestationofthemetabolicstatusintype2diabetesmellituspatients AT ibrahimilkeroz theadrenalglandvolumemeasurementsinmanifestationofthemetabolicstatusintype2diabetesmellituspatients AT muammerbilici theadrenalglandvolumemeasurementsinmanifestationofthemetabolicstatusintype2diabetesmellituspatients AT ismailserifoglu adrenalglandvolumemeasurementsinmanifestationofthemetabolicstatusintype2diabetesmellituspatients AT ibrahimilkeroz adrenalglandvolumemeasurementsinmanifestationofthemetabolicstatusintype2diabetesmellituspatients AT muammerbilici adrenalglandvolumemeasurementsinmanifestationofthemetabolicstatusintype2diabetesmellituspatients |